ICCM Stock Overview
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body.
+ 2 more risks
IceCure Medical Ltd Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₪3.74|
|52 Week High||₪15.27|
|52 Week Low||₪3.53|
|1 Month Change||-4.93%|
|3 Month Change||-29.35%|
|1 Year Change||-75.87%|
|3 Year Change||-14.35%|
|5 Year Change||-10.59%|
|Change since IPO||-99.41%|
Recent News & Updates
|ICCM||IL Medical Equipment||IL Market|
Return vs Industry: ICCM underperformed the IL Medical Equipment industry which returned -60.3% over the past year.
Return vs Market: ICCM underperformed the IL Market which returned -8.2% over the past year.
|ICCM Average Weekly Movement||16.8%|
|Medical Equipment Industry Average Movement||8.2%|
|Market Average Movement||5.1%|
|10% most volatile stocks in IL Market||8.3%|
|10% least volatile stocks in IL Market||3.3%|
Stable Share Price: ICCM is more volatile than 90% of IL stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: ICCM's weekly volatility has increased from 11% to 17% over the past year.
About the Company
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd Fundamentals Summary
|ICCM fundamental statistics|
Is ICCM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ICCM income statement (TTM)|
|Cost of Revenue||US$1.76m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Dec 05, 2022
|Earnings per share (EPS)||-0.41|
|Net Profit Margin||-419.79%|
How did ICCM perform over the long term?See historical performance and comparison